PowerIMMX
Immix Biopharma hires Brownstein Hyatt Farber Schreck to lobby.
What the record says
Issues named: Health Issues, Pharmacy.
- Stage
- Registered
- Date
- Nov 4, 2026
From the record
- Issues named
- Health Issues, Pharmacy
- First registration in our records
- No
Who is involved
- Immix BiopharmaClient
- Brownstein Hyatt Farber SchreckLobbying firm
Source: Lobbying disclosure (LDA) · Nov 4, 2026
What is not known yet
Which bills and agencies the firm will work on until its first quarterly report is filed.
Ask Intel
Source-backedWhy this is here: New lobbying firm hired. Published because: A listed company registers a lobbying firm (LDA registration), matched to its ticker by exact client name.